Two Sigma Advisers
SGNT

Two Sigma Advisers’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Two Sigma Advisers’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-9,222
Closed -$224K – 2132
2015
Q2 		$224K Buy
+9,222
New +$221K ﹤0.01% 1715
2014
Q1 		– Sell
-11,522
Closed -$293K – 2685
2013
Q4 		$293K Sell
11,522
-17,300
-60% -$391K ﹤0.01% 1912
2013
Q3 		$587K Buy
+28,822
New +$642K 0.01% 1278

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers's SGNT Position: Q3 2015 in Review

Two Sigma Advisers sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2015, closing a stake of 9,222 shares — an estimated $224K sold.

Two Sigma Advisers first reported a position in SGNT in Q3 2013 and held it in 3 quarters. The position peaked at $587K in Q3 2013. 127 funds tracked by Wall St. Rank hold SGNT as of Q3 2015.

  • Two Sigma Advisers reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2015 after selling out during the quarter.
  • Two Sigma Advisers sold 9,222 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2015, an estimated $224K.
  • Two Sigma Advisers first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 3 quarters.
  • Two Sigma Advisers's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $587K in Q3 2013.
  • 127 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2015.

Based on Two Sigma Advisers's 13F filing for Q3 2015, filed 16 Nov 2015.